AU2001229601A1 - Method and composition for modulating an immune response - Google Patents

Method and composition for modulating an immune response

Info

Publication number
AU2001229601A1
AU2001229601A1 AU2001229601A AU2960101A AU2001229601A1 AU 2001229601 A1 AU2001229601 A1 AU 2001229601A1 AU 2001229601 A AU2001229601 A AU 2001229601A AU 2960101 A AU2960101 A AU 2960101A AU 2001229601 A1 AU2001229601 A1 AU 2001229601A1
Authority
AU
Australia
Prior art keywords
modulating
composition
immune response
immune
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229601A
Inventor
George Hasko
Csaba Szabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inotek Corp
Original Assignee
Inotek Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inotek Corp filed Critical Inotek Corp
Publication of AU2001229601A1 publication Critical patent/AU2001229601A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001229601A 2000-01-24 2001-01-18 Method and composition for modulating an immune response Abandoned AU2001229601A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49188800A 2000-01-24 2000-01-24
US09491888 2000-01-24
PCT/US2001/001678 WO2001052860A2 (en) 2000-01-24 2001-01-18 Method and composition for modulating an immune response

Publications (1)

Publication Number Publication Date
AU2001229601A1 true AU2001229601A1 (en) 2001-07-31

Family

ID=23954080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229601A Abandoned AU2001229601A1 (en) 2000-01-24 2001-01-18 Method and composition for modulating an immune response

Country Status (2)

Country Link
AU (1) AU2001229601A1 (en)
WO (1) WO2001052860A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008007131A2 (en) * 2006-07-14 2008-01-17 Medical Research Council Treatment for demyelinating disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US6342484B1 (en) * 1993-06-30 2002-01-29 Board Of Regents, The University Of Texas Systems Method and compositions for promotion of wound treatment
DE4421536A1 (en) * 1994-06-20 1995-12-21 Hoechst Ag Phenyl-substituted alkenylcarboxylic acid guanidines bearing perfluoroalkyl groups, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (en) * 1995-11-14 1997-10-27 Gentili Ist Spa GLIBENCLAMIDE-METFORMIN ASSOCIATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR USE IN THE TREATMENT OF TYPE DIABETES MELLITUS
EP1097710B1 (en) * 1997-06-13 2014-08-20 Novo Nordisk A/S Combination product for treating niddm
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation

Also Published As

Publication number Publication date
WO2001052860A2 (en) 2001-07-26
WO2001052860A3 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001227586A1 (en) Application report and method for creating the same
AU2001261566A1 (en) Well service composition and method
AU2001286419A1 (en) Endourethral device and method
AU2001288372A1 (en) System and method for tele-ophthalmology
AU2001259112A1 (en) Interactive employment system and method
AU5784100A (en) Method for enhancing an immune response
AU2001243493A1 (en) Method and system for advertising
AU2001219651A1 (en) Mulch composition and method
AU2001286651A1 (en) Microparticle composition and method
AU2001245288A1 (en) Overhanging form system and method of using the same
IL145891A0 (en) Methods and compositions for modulating an immune response
AU7968398A (en) Compositions, devices, kit and method for modulating immune response
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2001279850A1 (en) Method and arrangement for studsystem
AU2002213227A1 (en) Generalizer system and method
AU7474100A (en) Methods and compositions for reducing immune response
AU2001233932A1 (en) Method and composition
AU2273397A (en) Methods and compositions for modulating an immune response
AU2001293118A1 (en) Dosimeter and method for using the same
AU2001290346A1 (en) System and method for simulated engagement
AU2001288736A1 (en) Method and composition for enhancing vision
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU2002239775A1 (en) Chemical-library composition and method
AU2001249519A1 (en) An educational aid and method
AU2002248646A1 (en) Compositions and methods for modulating an immune response